HK1214522A1 - 醋酸格拉默的口腔透黏膜给药 - Google Patents

醋酸格拉默的口腔透黏膜给药 Download PDF

Info

Publication number
HK1214522A1
HK1214522A1 HK16102543.0A HK16102543A HK1214522A1 HK 1214522 A1 HK1214522 A1 HK 1214522A1 HK 16102543 A HK16102543 A HK 16102543A HK 1214522 A1 HK1214522 A1 HK 1214522A1
Authority
HK
Hong Kong
Prior art keywords
glatiramer acetate
transmucosal delivery
oral transmucosal
percent
film composition
Prior art date
Application number
HK16102543.0A
Other languages
English (en)
Chinese (zh)
Inventor
Geister Ursula
Schweizer Stephan
Buerger Martina
Stefan Ralph
Huber Gerald
Pries Tanja
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of HK1214522A1 publication Critical patent/HK1214522A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16102543.0A 2012-12-21 2013-12-20 醋酸格拉默的口腔透黏膜给药 HK1214522A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261745243P 2012-12-21 2012-12-21
US61/745,243 2012-12-21
PCT/US2013/077041 WO2014100643A1 (en) 2012-12-21 2013-12-20 Oral transmucosal delivery of glatiramer acetate

Publications (1)

Publication Number Publication Date
HK1214522A1 true HK1214522A1 (zh) 2016-07-29

Family

ID=50979258

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16102543.0A HK1214522A1 (zh) 2012-12-21 2013-12-20 醋酸格拉默的口腔透黏膜给药
HK16102019.5A HK1214133A1 (zh) 2012-12-21 2013-12-20 醋酸格拉默的口腔透黏膜给药

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16102019.5A HK1214133A1 (zh) 2012-12-21 2013-12-20 醋酸格拉默的口腔透黏膜给药

Country Status (15)

Country Link
US (1) US20150328277A1 (cg-RX-API-DMAC7.html)
EP (1) EP2934493A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016503066A (cg-RX-API-DMAC7.html)
KR (1) KR20150111919A (cg-RX-API-DMAC7.html)
CN (1) CN104869984A (cg-RX-API-DMAC7.html)
AU (1) AU2013361057A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015014092A2 (cg-RX-API-DMAC7.html)
CA (1) CA2895457A1 (cg-RX-API-DMAC7.html)
EA (1) EA201591187A1 (cg-RX-API-DMAC7.html)
HK (2) HK1214522A1 (cg-RX-API-DMAC7.html)
IL (1) IL239279A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015007794A (cg-RX-API-DMAC7.html)
SG (1) SG11201504461QA (cg-RX-API-DMAC7.html)
WO (1) WO2014100643A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201505050B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA025780B1 (ru) 2010-10-11 2017-01-30 Тева Фармасьютикал Индастриз Лтд. Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат
MX2014004309A (es) 2011-10-10 2015-07-06 Teva Pharma Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer.
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
US10493122B2 (en) 2014-03-17 2019-12-03 Mapi Pharma Ltd. Sublingual delivery of glatiramer acetate
US10323289B2 (en) 2017-06-26 2019-06-18 Institut Pasteur Treatments to eliminate HIV reservoirs and reduce viral load

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US7022663B2 (en) * 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
US20060210616A1 (en) * 2005-03-17 2006-09-21 Linder Barry J Therapeutic patch for ophthalmologic and cosmetic use
US20070021325A1 (en) * 2005-07-21 2007-01-25 Mediplex Corporation Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
KR100809404B1 (ko) * 2005-12-28 2008-03-05 (주)스피어테크 리포좀화 시킨 나노용매를 함유하는 경피흡수 점착시트형 화장료 조성물 및 제조방법
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
RU2436565C2 (ru) * 2006-02-17 2011-12-20 Новартис Аг Распадающиеся пероральные пленки
WO2008006226A1 (en) * 2006-07-14 2008-01-17 Wine, Harvey Transdermal formulations of synthetic cannabinoids and nano colloidal silica
AU2007329375A1 (en) * 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
JP5177447B2 (ja) * 2007-06-07 2013-04-03 佐藤製薬株式会社 速溶性及び可撓性を有するフィルム製剤
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
US20100278899A1 (en) * 2007-12-06 2010-11-04 Lintec Corporation Edible film

Also Published As

Publication number Publication date
WO2014100643A1 (en) 2014-06-26
JP2016503066A (ja) 2016-02-01
ZA201505050B (en) 2016-10-26
CN104869984A (zh) 2015-08-26
SG11201504461QA (en) 2015-07-30
WO2014100643A8 (en) 2015-06-25
EP2934493A4 (en) 2016-09-07
HK1214133A1 (zh) 2016-07-22
EP2934493A1 (en) 2015-10-28
EA201591187A1 (ru) 2016-03-31
CA2895457A1 (en) 2014-06-26
US20150328277A1 (en) 2015-11-19
AU2013361057A1 (en) 2015-07-30
BR112015014092A2 (pt) 2017-07-11
KR20150111919A (ko) 2015-10-06
MX2015007794A (es) 2015-09-04
IL239279A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
MX2013002422A (es) Sales de lorcaserina con acidos opticamente activos.
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2012042371A3 (en) Pharmaceutical composition
WO2012095752A3 (en) Personal care compositions
WO2011131943A8 (en) Pharmaceutical compositions
WO2011156518A3 (en) Estrogen receptor modulators and uses thereof
WO2012156296A8 (en) Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
WO2011088199A3 (en) Stabilization of zinc oxide film in oral compositions
HUE037742T2 (hu) Szubsztituált azolok, vírusellenes aktív adalék, gyógyszerészeti készítmény, az elõállításukat célzó eljárás és alkalmazásuk
MY173521A (en) Trpv4 antagonists
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
HK1200314A1 (en) R(+)-n-methyl-propargyl-aminoindan
WO2013055687A3 (en) R(+)-n-formyl-propargyl-aminoindan
HK1214523A1 (zh) 醋酸格拉替雷的透粘膜给药
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
WO2014100643A8 (en) Oral transmucosal delivery of glatiramer acetate
WO2012016042A3 (en) Glatiramer acetate molecular weight markers
WO2011135580A3 (en) Pharmaceutical compositions of sirolimus
WO2014064652A3 (en) Stable pharmaceutical composition of peginterferon alpha-2b
AR084224A1 (es) Composicion de relleno que comprende grano integral hidrolizado
WO2012093973A3 (en) Compositions in the form of tablets comprising acarbose
CR11755A (es) Dronedarona para la prevencion de la cardioversion
IL225440A (en) Cyclohexane derivatives, preparations containing them and their uses
WO2012029074A3 (en) Pharmaceutical compositions of linezolid